Patent 7683027 was granted and assigned to Diobex on March, 2010 by the United States Patent and Trademark Office.
Provided are methods of administering glucagon so as to reduce the risk of hypoglycemic unawareness. Also provided are methods of returning hypoglycemic awareness to a subject.